Howard Capital Management’s Gilead Sciences GILD Stock Holding History

Howard Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.98M	Buy	39,385 +22,533	+134%	+$2.97M	0.06%	110
2026 Q1	$2.35M	Sell	16,852 -23,096	-58%	-$3.23M	0.04%	112
2025 Q4	$4.9M	Buy	39,948 +899	+2%	+$109K	0.06%	90
2025 Q3	$4.33M	Sell	39,049 -45	-0.1%	-$5.12K	0.06%	100
2025 Q2	$4.33M	Buy	39,094 +5,702	+17%	+$607K	0.06%	94
2025 Q1	$3.74M	Sell	33,392 -8,530	-20%	-$880K	0.09%	84
2024 Q4	$3.87M	Buy	41,922 +4,574	+12%	+$412K	0.06%	96
2024 Q3	$3.13M	Buy	+37,348	New	+$2.85M	0.05%	111
2018 Q4	–	Sell	-150,082	Closed	-$11.5M	–	30
2018 Q3	$11.5M	Sell	150,082 -7	-0%	-$529	1.11%	33
2018 Q2	$11.6M	Sell	150,089 -117,238	-44%	-$8.28M	1.28%	11
2018 Q1	$20.1M	Buy	267,327 +169,761	+174%	+$13.5M	2.54%	7
2017 Q4	$6.99M	Buy	+97,566	New	+$7.41M	1.11%	57

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Howard Capital Management's GILD Position: Q2 2026 in Review

Howard Capital Management increased its Gilead Sciences (GILD) stake by 134% in Q2 2026, buying an estimated $2.97M and bringing the position to 39,385 shares worth $4.98M. The position accounts for 0.06% of the portfolio, ranked #110.

Howard Capital Management first reported a position in GILD in Q4 2017 and has held it in 12 quarters since. The position peaked at $20.1M in Q1 2018. 911 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Howard Capital Management held 39,385 shares of Gilead Sciences worth $4.98M as of Q2 2026.
Howard Capital Management bought 22,533 Gilead Sciences shares in Q2 2026, an estimated $2.97M.
Gilead Sciences made up 0.06% of Howard Capital Management's portfolio in Q2 2026, its #110 holding.
Howard Capital Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 12 quarters since.
Howard Capital Management's Gilead Sciences position peaked at $20.1M in Q1 2018.
911 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.